Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Apo-B100 antibody (FITC)

This anti-Apo-B100 antibody is a Goat Polyclonal antibody detecting Apo-B100 in . Suitable for Human.
Catalog No. ABIN7454057

Quick Overview for Apo-B100 antibody (FITC) (ABIN7454057)

Target

See all Apo-B100 Antibodies
Apo-B100 (Apoprotein B100 (Apo-B100))

Reactivity

  • 26
  • 3
  • 3
  • 2
  • 1
Human

Host

  • 17
  • 14
  • 3
  • 1
Goat

Clonality

  • 18
  • 17
Polyclonal

Conjugate

  • 29
  • 4
  • 1
  • 1
This Apo-B100 antibody is conjugated to FITC

Application

Please inquire

Clone

F06
  • Purpose

    Goat anti-Human Apo B-100 [F06] Antibody FITC Conjugated

    Immunogen

    Human Apolipoprotein B100

    Isotype

    IgG
  • Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02 % Sodium azide, pH 7.2

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Expiry Date

    12 months
  • Target

    Apo-B100 (Apoprotein B100 (Apo-B100))

    Alternative Name

    ApoB-100

    Background

    Background: ApoB exists in human plasma in two isoforms, ApoB-48 (Chen et al., 1987) and Apo B-100 (Wei et al., 1985, Yang et al., 1986a, 1989a,b, 1990, Chen et al., 1986, Yang et al., 1990, Yang and Pownall, 1992). Apo B-100 is the major physiological ligand for the LDL receptor. Apo B-100 is a large monomeric protein, containing 4536 amino acids (m.w. 515 kDa, Yang et al., 1986b). Apo B-100 is synthesized in the liver and is required for the assembly of VLDL. It is found in LDL and VLDL after the removal of the Apo A, E and C. Apo B-48 is present in chylomicrons and their remnants. It is essential for the intestinal absorption of dietary lipids. Apo B levels correlate with the risk of coronary disease. The Apo B protein is directly involved in the retention of LDL with the arterial wall (Olofsson and Boren, 2012). Apo B-48 is synthesized in the small intestine. It comprises approximately half of the N-terminal region of ApoB-100 and is the result of posttranscriptional mRNA editing by a stop codon in the intestine not found in the liver.

    Gene ID

    338

    NCBI Accession

    NP_000375

    UniProt

    P04114
You are here:
Chat with us!